Shaanxi Kanghui Pharmaceutical Balance Sheet Health
Financial Health criteria checks 2/6
Shaanxi Kanghui Pharmaceutical has a total shareholder equity of CN¥974.4M and total debt of CN¥695.7M, which brings its debt-to-equity ratio to 71.4%. Its total assets and total liabilities are CN¥2.0B and CN¥1.0B respectively.
Key information
71.4%
Debt to equity ratio
CN¥695.71m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥126.90m |
| Equity | CN¥974.35m |
| Total liabilities | CN¥1.03b |
| Total assets | CN¥2.01b |
Recent financial health updates
No updates
Recent updates
Insufficient Growth At Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Hampers Share Price
Sep 30
Market Cool On Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues Pushing Shares 28% Lower
Jun 09Little Excitement Around Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues
Feb 27Financial Position Analysis
Short Term Liabilities: 603139's short term assets (CN¥726.4M) exceed its short term liabilities (CN¥616.5M).
Long Term Liabilities: 603139's short term assets (CN¥726.4M) exceed its long term liabilities (CN¥416.4M).
Debt to Equity History and Analysis
Debt Level: 603139's net debt to equity ratio (58.4%) is considered high.
Reducing Debt: 603139's debt to equity ratio has increased from 0.4% to 71.4% over the past 5 years.
Debt Coverage: 603139's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 603139's interest payments on its debt are well covered by EBIT.